Paul W. Hoelscher - 20 Jan 2022 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (OKUR)

Role
Director
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Issuer symbol
OKUR
Transactions as of
20 Jan 2022
Net transactions value
$0
Form type
4
Filing time
24 Jan 2022, 15:58:12 UTC
Previous filing
06 Jan 2022
Next filing
24 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock Option (right to buy) Award $0 +35,000 $0.000000 35,000 20 Jan 2022 Common Stock 35,000 $8.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period.